Intervention

Cardiopulmonary exercise test

ClinicalTrials.gov intervention label

Clinical trials10
Recruiting0
Common conditions23
Lead sponsors shown10

Clinical trials

10 shown
Impact of Sarcopenia on Dyspnea in Patients With AsthmaNCT06870890 · 2025-03-25
NOT_YET_RECRUITING
Physical Activity in Children With Wolff-Parkinson-White SyndromeNCT06349109 · 2024-03-01
COMPLETED
CPET in Evaluation of PH in COPD PatientsNCT04035148 · 2019-10-01
UNKNOWN
Effects of Hormonal Anabolic Deficiency and Neurovascular Alterations on Mortality in Male Patients With Heart FailureNCT03463226 · 2016-06-30
COMPLETED
Surfactant Derived Protocol in Heart FailureNCT06896461 · 2016-05-06
COMPLETED
Left Ventricular Fibrosis in Chronic Kidney DiseaseNCT03176862 · 2015-09-01
UNKNOWN
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast CancerNCT02494869 · 2015-07-01
ACTIVE_NOT_RECRUITING
Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow ObstructionNCT02458703 · 2015-05-01
UNKNOWN
Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)NCT01900600 · 2013-04-01
COMPLETED
Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection FractionNCT01747785 · 2012-06-01
TERMINATED

Common conditions

Heart Failure3Asthma2COPD2Adipokines1Cardio-Renal Syndrome1Chronic Kidney Diseases1Cytokines1Dyspnea1Dyspnea; Asthmatic1Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l)1Hereditary Hemorrhagic Telangiectasia1High Risk for Developing Breast Cancer1Muscle Disorder1Myocardial Fibrosis1Myokine1Prior Acute Myocardial Infarction1Pulmonary Arteriovenous Malformations1Pulmonary Hypertension Secondary1Reduced Left Ventricle Ejection Fraction (<50%)1Sarcopenia1Symptoms of Heart Failure (NYHA Class II-III)1Uraemic Cardiomyopathy1Wolff-Parkinson-White Syndrome1

Trial status mix

COMPLETED4
UNKNOWN3
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
TERMINATED1

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.